LIQTECH INTERNATIONAL INC
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-11-14.
0001437749-25-034985
Item 2. Management's Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-13.
0001437749-26-016536
Item 2. Management's Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 55 previous paragraphs and 40 current paragraphs.
22 unchanged; 11 reworded; 7 added; 20 removed; 2 previous and 0 current paragraphs rearranged.
Tables are not compared: 4 previous and 3 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (7)
Current report
Revenue for the three months ended March 31, 2026 was $4,136,320 compared to $4,617,541 for the same period in 2025, representing a decrease of $481,221, or 10.4%. The decrease was solely attributable to a reduction in system sales, reflecting a significant Water for Energy delivery in 2025 that did not recur in 2026. Within the Systems segment, sales to both the Pool and Marine segments increased significantly. Furthermore, deliveries of Filters, Membranes, and Components increased during the period.
Current report
Total operating expenses for the three months ended March 31, 2026 were$2,670,953, representing an increase of$360,568, or 15.6%, compared to$2,310,385 for the same period in 2025. Approximately 60% of the increase relates to foreign exchange rate developments, as the average USD/DKK exchange rate for the three months ended March 31st, was 6.385 in 2026 and 7.092 in 2025.
Current report
Selling expenses for the three months ended March 31, 2026 were$980,674 compared to$718,016 for the same period in 2025, representing an increase of$262,658, or 36.6%. Excluding the impact of foreign exchange rate developments, costs increased primarily due to the full-year effect of hires within the joint venture in China, Nantong JiTRI LiqTech Green Energy Technology Co., Ltd. (the “JV”), as well as continued investments in the sales organization across the U.S. and Europe, and annualization of the Service Center cost in the U.S.
Current report
Research and development expenses for the three months ended March 31, 2026 were$276,134 compared to$230,123 for the same period in 2025, representing an increase of$46,011, or 20.0%. The increase was primarily attributed to membrane development costs and cost related to development of Marine systems.
Current report
The Company has experienced operating losses and cash outflows from continuing operations and will require additional funding to support operations for the twelve months following the issuance of these financial statements. These conditions raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Current report
Management has implemented cost optimization operational initiatives and working capital control designed to improve liquidity and support a sustainable path toward profitability, supported by an updated strategic focus and strengthened leadership. The Company continues to evaluate financing alternatives and strategic opportunities to enhance its capital position. While there can be no assurance that additional funding will be obtained on favorable terms, management believes its ongoing initiatives position the Company to support operations and advance its strategic objectives.
Current report
Three months ended March 31, 2026 compared tothree months ended March 31, 2025
Removed paragraphs (20)
Previous report
Revenue for the three months ended September 30, 2025 was $3,807,274 compared to $2,478,221 for the same period in 2024, representing an increase of $1,329,053, or 53.6%. The favorable change was attributable to an increase in liquid filtration systems, specifically an increase in pool system deliveries and aftermarket sales, along with increased sales of plastics products, partially offset by a decrease in deliveries of DPFs.
Previous report
Total operating expenses for the three months ended September 30, 2025 were$2,080,880, representing a decrease of$299,560, or 12.6%, compared to$2,380,440 for the same period in 2024.
Previous report
Selling expenses for the three months ended September 30, 2025 were$541,259 compared to$610,713 for the same period in 2024, representing a decrease of$69,454, or 11.4%. The decrease in selling expenses is related to the release of a bad debt provision due to aging improvements as well as lower depreciatio,n partially offset by costs associated with the newly formed joint venture in China, Nantong JiTRI LiqTech Green Energy Technology Co., Ltd.(the "JV"). The primary focus of the JV is to develop and commercialize systems for the marine water treatment market in China.
Previous report
Research and development expenses for the three months ended September 30, 2025 were$269,426 compared to$278,361 for the same period in 2024, representing a decrease of$8,935, or 3.2%. The decrease was primarily attributed to one-time exit costs of a loss-making external development project in the prior-year period and, a reduction in the average number of employees engaged in research and development activity as the Company streamlined and centralized the R&D function.
Previous report
Comparison of the Nine Months Ended September 30, 2025, and September 30, 2024
Previous report
Revenues
Previous report
Revenue for thenine months ended September 30, 2025 was$13,382,304 compared to$11,198,627 for the same period in 2024, representing an increase of$2,183,677, or 19.5%. The favorable change was attributable to an increase in liquid filtration systems, specifically a full-scale PureFlow™ system delivery and pool filtration systems, increased sales of plastics products, and increased sales of ceramic membranes, partially offset by a decrease in deliveries of DPFs.
Previous report
Gross Profit (Loss)
Previous report
Gross profit for thenine months ended September 30, 2025 was$1,357,512 (representing a gross profit margin of 10.1%) compared to a gross profit of$778,780 (representing a gross profit margin of 7.0%) for the same period in 2024, marking a increase of$578,732, or 74.3%. This increase was primarily driven by the higher revenue related to the delivery of a first time full-scale PureFlow™ liquid filtration system to the U.S. Also impacting gross profit was the improved utilization of our membrane manufacturing capacity. This impact was partially offset by lower depreciation expenses. Included in the gross profit was depreciation of$1,176,237 and$1,372,482 for thenine months ended September 30, 2025, and 2024, respectively.
Previous report
Expenses
Previous report
Total operating expenses for thenine months ended September 30, 2025 were$6,985,712, representing a decrease of$515,580, or 6.9%, compared to$7,501,292 for the same period in 2024.
Previous report
Selling expenses for thenine months ended September 30, 2025 were$2,071,843 compared to$1,983,414 for the same period in 2024, representing an increase of$88,429, or 4.5%. The increase in selling expenses was mainly related to lower sales commissions in 2024, along with the cost associated with the JV. The primary focus of the JV is to develop and commercialize systems for the marine water treatment market in China. The increase was partially offset by decreased bad debt expense and lower depreciation.
Previous report
General and administrative expenses for thenine months ended September 30, 2025 were$4,171,764 compared to$4,577,413 for the same period in 2024, representing a decrease of$405,649, or 8.9%. The decrease was mainly attributable to non-recurring costs in the comparable period related to recruitment expenses associated with the CFO transition along with savings on external consulting services during this period. Included in general and administrative expenses were non-cash compensation of $730,335 and $521,791 for thenine months ended September 30, 2025, and 2024, respectively.
Previous report
Research and development expenses for thenine months ended September 30, 2025 were$742,105 compared to$940,465 for the same period in 2024, representing a decrease of$198,360, or 21.1%. The decrease was primarily attributed to one-time exit costs of a loss-making external development project in the prior-year period and a reduction in the average number of employees engaged in research and development activity as the Company streamlined and centralized the R&D function.
Previous report
Other Income (Expenses)
Previous report
Other expenses for thenine months ended September 30, 2025 were$351,764 compared to other expenses of$656,659 for the comparable period in 2024, representing a favorable change of$304,895, or 46.4%. The change was primarily attributable to significant losses on the disposal of property and equipment in the prior-year period, partially offset by a lower gain on currency transactions for thenine months ended September 30, 2025.
Previous report
Net Loss
Previous report
Based on current projections, which are subject to significant uncertainties--including the duration and severity of global macroeconomic issues, trade wars and associated tariffs, geopolitical instability, commodity price volatility, and continued global supply chain disruptions-the Company believes that the cash on hand, as well as ongoing cash generated from operations, will be sufficient to cover its capital requirements and committed investments for the next 12 months.
Previous report
While the Company anticipates that its proactive measures will be sufficient to protect the business over the coming 12 months, the Company cannot predict the specific duration and severity of the unfavorable market dynamics that may adversely affect the business. In the future, the Company may experience reduced or changed demand for its products and services, especially if there is a global recession, structural shift in regulation, or the escalating interest rates and tariffs that adversely impact the investment decisions of our customers.
Previous report
Nine months ended September 30, 2025 compared tonine months ended September 30, 2024
Reworded paragraphs (11)
Previous wording
LiqTech International, Inc. is a clean technology company that provides state-of-the-art gas and liquid purification products by manufacturing ceramic silicon carbide filters and membranes as well as developing industry-leading and fully automated filtration solutions and systems. For more than two decades, we have developed and manufactured products of re-crystallized silicon carbide. We specialize in three business areas: ceramic membranes for liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. Using nanotechnology, we develop proprietary products using patented silicon carbide technology. Our products are based on innovative silicon carbide membranes that facilitate new applications and improve existing technologies. We market our products from our offices in Denmark and through local representatives and distributors. The products are shipped directly to customers from our production facilities in Denmark.
Current wording
LiqTech International, Inc. is a clean technology company that provides state-of-the-art gas and liquid purification products by manufacturing ceramic silicon carbide filters and membranes as well as developing industry-leading and fully automated filtration solutions and systems. For more than two decades, we have developed and manufactured products of re-crystallized silicon carbide. We specialize in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. Using nanotechnology, we develop proprietary products using patented silicon carbide technology. Our products are based on innovative silicon carbide membranes that facilitate new applications and improve existing technologies. We market our products from our offices in Denmark and through local representatives and distributors. The products are shipped directly to customers from our production facilities in Denmark.
Previous wording
At present, we conduct our operations in the Kingdom of Denmark, US and China, with locations in the Copenhagen area, Hobro, Fort Worth and Nantong.
Current wording
At present, we conduct our operations in the Kingdom of Denmark, the U.S. and China, with locations in the Copenhagen area, Hobro, Fort Worth and Nantong.
Previous wording
Our strategy is to leverage our core competencies in material science, advanced filtration, and systems integration, creating differentiated products with compelling value propositions to penetrate attractive end markets with value creation regulatory tailwinds and sustainability implications. Essential imperatives associated with our strategy include the following:
Current wording
Our strategy is to leverage our core competencies in material science, advanced filtration, systems integration, and application knowledge, creating differentiated products with compelling value propositions to penetrate attractive end markets with customer needs and regulatory tailwind. Essential imperatives associated with our strategy include the following:
Previous wording
Gross profit for the three months ended September 30, 2025 was$747,878 (representing a gross profit margin of 19.6%) compared to a gross profit loss of$209,533 (representing a gross profit margin of -8.5%) for the same period in 2024, marking an increase of$957,411, or 456.9%. This increase was primarily driven by system sales utilization of our manufacturing capacity for membranes and low depreciation expenses offset by write-offs for slow-moving inventory linked to DPF activity. Included in the gross profit was depreciation of$371,654 and$478,902 for the three months ended September 30, 2025, and 2024, respectively.
Current wording
Gross profit for the three months ended March 31, 2026 was$393,744 (representing a gross profit margin of 9.5%) compared to a gross profit of$125,056 (representing a gross profit margin of 2.7%) for the same period in 2025, marking an increase of$268,688, or 214.9%. This increase was primarily driven by mix towards higher value system sales, better utilization of our manufacturing capacity, procurement effects on prices, and low depreciation expenses. Included in the gross profit was depreciation of $330,006 and $392,292 for the three months ended March 31, 2026, and 2025, respectively.
Previous wording
General and administrative expenses for the three months ended September 30, 2025 were$1,270,195 compared to$1,491,366 for the same period in 2024, representing a decrease of$221,171, or 14.8%. While overall expenses remained stable, an increase in non-cash compensation was offset by corresponding decrease in salaries. Included in general and administrative expenses were non-cash compensation of $258,538 and $157,000 for the three months ended September 30, 2025, and 2024, respectively.
Current wording
General and administrative expenses for the three months ended March 31, 2026 were$1,414,145 compared to$1,362,246 for the same period in 2025, representing an increase of$51,899, or 3.8%. Adjusting for foreign exchange rate developments, expenses remained stable and below general inflation, as filing of open positions were covered by savings on other overhead expenses. Included in general and administrative expenses were non-cash compensation of $218,252 and $241,245 for the three months ended March 31, 2026, and 2025, respectively.
Previous wording
Other expenses for the three months ended September 30, 2025 were$127,135 compared to other expenses of$260,614 for the comparable period in 2024, representing a favorable change of$133,479, or 51.2%. The change was primarily attributable to slower amortization of debt discount, reduced losses on currency transactions, and a decrease of net interest expenses for the three months ended September 30, 2025
Current wording
Other expenses for the three months ended March 31, 2026 were$448,267 compared to other expenses of$173,352 for the comparable period in 2025, representing an increase of$274,915, or 158.6%. The change was primarily attributable to losses on foreign currency transactions, lower interest income, and accrued interests on the senior promissory notes, partly balanced by lower amortization of debt discount, and a decrease of net interest expenses for the three months ended March 31, 2026
Previous wording
As a result of the cumulative effect of the factors described above, we reported a net loss for the three months ended September 30, 2025 of$1,459,762 compared to$2,840,526 for the comparable period in 2024, representing a favorable change in net loss of$1,380,764, or 48.6%.
Current wording
As a result of the cumulative effect of the factors described above, we reported a net loss for the three months ended March 31, 2026 of$2,725,099 compared to$2,358,342 for the comparable period in 2025, representing an increase in net loss of$366,757, or 15.6%.
Previous wording
The Company has historically financed operations through offerings of equity or debt instruments, internally generated cash from operations, and our available lines of credit. On September 30, 2025, we had cash of $7,354,024 and net working capital of $13,406,883, and on December 31, 2024, we had cash of $10,868,728 and net working capital of $15,736,809. On September 30, 2025, our net working capital had decreased by $2,329,926 compared to December 31, 2024, mainly as a result of a focused effort to improve working capital through improved inventory management.
Current wording
The Company has historically financed operations through offerings of equity or debt instruments, internally generated cash from operations, and our available lines of credit. On March 31, 2026, we had cash of $2,732,739 and net working capital of $8,483,730, and on December 31, 2025, we had cash of $5,070,385 and net working capital of $11,237,788. On March 31, 2026, our net working capital had decreased by $2,754,058 compared to December 31, 2025, mainly as a result of a reduction in cash and cash equivalents used to fund operating losses
Previous wording
Cash flows from operating activities for the period ending September 30, 2025 derived from the net loss for the period, adjusted for non-cash items and changes in assets and liabilities. Cash flows used in operating activities for thenine months ended September 30, 2025 were $3,977,121 representing a favorable change of $1,551,321 compared to cash flows used in operating activities of $5,528,442 for thenine months ended September 30, 2024. The cash flows used in operating activities for the period consists mainly of the net loss of $5,978,890, adjusted for depreciation and other non-cash-related items of $2,884,217, and an increase in accounts receivables of $1,010,624, partially offset by decrease in contract assets of $863,564 and inventories of $190,640.
Current wording
Cash flows used in operating activities for the three months ended March 31, 2026 were $1,941,544 representing an increase of $644,358 compared to cash flows used in operating activities of $1,297,186 for the three months ended March 31, 2025. The cash flows used in operating activities for the period consists mainly of the net loss of $2,725,099, adjusted for depreciation and other non-cash-related items of $835,210, an increase in accounts receivables of $317,277, prepaid expenses and other current assets of $399,522, and partially offset by an increase in accounts payable of $526,117.
Previous wording
Cash flows used in investing activities were $173,139 for thenine months ended September 30, 2025 as compared to cash flows used in investing activities of $28,767 for thenine months ended September 30, 2024, representing an unfavorable change of $144,372. The investing activities include general purchases of production equipment to continue optimizing production throughput and the internal production of rental assets, partly offset by proceeds from the disposal of production equipment in our Ballerup facility.
Current wording
Cash flows used in investing activities were $269,724 for the three months ended March 31, 2026 as compared to cash flows used in investing activities of $110,860 for the three months ended March 31, 2025, representing a change of $158,864. The investing activities include general purchases of production equipment to continue optimizing production throughput and the internal production of rental assets. For the three months ended March 31, 2026, the main additions were investments in assembly equipment in our JV in China and in the U.S. Service Center.
Previous wording
Cash flows provided from financing activities were $787,024 for thenine months ended September 30, 2025 compared to cash flows used by financing activities of $125,718 for thenine months ended September 30, 2024, representing a favorable change of $912,742. The finance activities include proceeds from a long-term loan and capital contribution from the noncontrolling interest in the JV. Additionally, in the prior-year period, finance activities included the repayment of a lease agreement.
Current wording
Cash flows provided from financing activities were $(311,911) for the three months ended March 31, 2026 compared to cash flows used by financing activities of $989,722 for the three months ended March 31, 2025, representing a change of $1,301,633. Financing activities primarily consisted of repayments of lease obligations and the acquisition of common stock to satisfy tax withholding obligations. Additionally, in the prior-year period, the Company received proceeds from a long-term loan as well as a capital contribution from the noncontrolling interest in the joint venture.
Rearranged previous paragraphs (2)
Previous report — wording carried elsewhere
The following table sets forth our revenues, expenses, and net loss for thenine months ended September 30, 2025, and 2024:
Previous report — wording carried elsewhere
As a result of the cumulative effect of the factors described above, we reported a net loss for thenine months ended September 30, 2025 of$5,978,890 compared to$7,340,521 for the comparable period in 2024, representing a decrease in net loss of$1,361,631, or 18.5%.